BR9810288A - Teste diagnóstico especìfico para espécie para identificar infecção de um mamìfero, como um humano, com chlamydia pneumoniae, fragmento de ácido nucleico derivado de chlamydia pneumoniae, proteìna derivada de chlamydia pneumoniae, anticorpo monoespecìfico policlonal, kit diagnóstico para o diagnóstico de infecção de um mamìfero, como um humano, com chlamydia pneumoniae, composição para imunizar um mamìfero comoum humano, contra chlamydia pneumoniae, uso de uma proteìna, e, uso de um fragmento de ácido nucleico. - Google Patents
Teste diagnóstico especìfico para espécie para identificar infecção de um mamìfero, como um humano, com chlamydia pneumoniae, fragmento de ácido nucleico derivado de chlamydia pneumoniae, proteìna derivada de chlamydia pneumoniae, anticorpo monoespecìfico policlonal, kit diagnóstico para o diagnóstico de infecção de um mamìfero, como um humano, com chlamydia pneumoniae, composição para imunizar um mamìfero comoum humano, contra chlamydia pneumoniae, uso de uma proteìna, e, uso de um fragmento de ácido nucleico.Info
- Publication number
- BR9810288A BR9810288A BR9810288-5A BR9810288A BR9810288A BR 9810288 A BR9810288 A BR 9810288A BR 9810288 A BR9810288 A BR 9810288A BR 9810288 A BR9810288 A BR 9810288A
- Authority
- BR
- Brazil
- Prior art keywords
- chlamydia pneumoniae
- human
- mammal
- nucleic acid
- protein
- Prior art date
Links
- 241001647372 Chlamydia pneumoniae Species 0.000 title abstract 12
- 108090000623 proteins and genes Proteins 0.000 title abstract 7
- 102000004169 proteins and genes Human genes 0.000 title abstract 6
- 208000015181 infectious disease Diseases 0.000 title abstract 5
- 241000124008 Mammalia Species 0.000 title abstract 4
- 238000003745 diagnosis Methods 0.000 title abstract 4
- 150000007523 nucleic acids Chemical class 0.000 title abstract 4
- 108020004707 nucleic acids Proteins 0.000 title abstract 3
- 102000039446 nucleic acids Human genes 0.000 title abstract 3
- 239000012634 fragment Substances 0.000 title abstract 2
- 241000894007 species Species 0.000 title abstract 2
- 238000009007 Diagnostic Kit Methods 0.000 title 1
- 238000002405 diagnostic procedure Methods 0.000 title 1
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 2
- 108010052285 Membrane Proteins Proteins 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 244000052769 pathogen Species 0.000 abstract 1
- 230000001717 pathogenic effect Effects 0.000 abstract 1
- 230000007170 pathology Effects 0.000 abstract 1
- 230000000241 respiratory effect Effects 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/125—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Chlamydiales (O)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
"TESTE DIAGNóSTICO ESPECìFICO PARA ESPéCIE PARA IDENTIFICAR INFECçãO DE UM MAMìFERO, COMO UM HUMANO, COM CHLAMYDIA PNEUMONIAE, FRAGMENTO DE áCIDO NUCLEICO DERIVADO DE CHLAMYDIA PNEUMONIAE, PROTEìNA DERIVADA DE CHLAMYDIA PNEUMONIAE, ANTICORPO MONOESPECìFICO POLICLONAL, KIT DIAGNóSTICO PARA O DIAGNóSTICO DE INFECçãO DE UM MANìFERO, COMO UM HUMANO, COM CHLAMYDIA PNEUMONIAE, COMPOSIçãO PARA IMUNIZAR UM MAMìFERO COMO UM HUMANO, CONTRA CHLAMYDIA PNEUMONIAE, USO DE UMA PROTEìNA, E, USO DE UM FRAGMENTO DE áCIDO NUCLEICO" A invenção refere-se à identificação de membros de uma família de genes de patógeno respiratório humano Chlamydia pneumoniae, codificando as proteínas de membrana exposta na superfície de um tamanho de aproximadamente 89-101 kDa e de 56-57 kDa, preferivelmente cerca de 89,6 - 100,3 kDa e cerca de 56,1 kDa. A invenção refere-se a novas sequências de DNA, a sequência de aminoácidos deduzidas de proteínas correspondentes e ao uso de sequências de DNA e as proteínas no diagnóstico de infecções provocadas por C. pneumoniae, em patologia, em epidemiologia e como componentes de vacina.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK74497 | 1997-06-23 | ||
| PCT/DK1998/000266 WO1998058953A2 (en) | 1997-06-23 | 1998-06-19 | Surface exposed proteins from chlamydia pneumoniae |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9810288A true BR9810288A (pt) | 2000-09-19 |
Family
ID=8097044
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9810288-5A BR9810288A (pt) | 1997-06-23 | 1998-06-19 | Teste diagnóstico especìfico para espécie para identificar infecção de um mamìfero, como um humano, com chlamydia pneumoniae, fragmento de ácido nucleico derivado de chlamydia pneumoniae, proteìna derivada de chlamydia pneumoniae, anticorpo monoespecìfico policlonal, kit diagnóstico para o diagnóstico de infecção de um mamìfero, como um humano, com chlamydia pneumoniae, composição para imunizar um mamìfero comoum humano, contra chlamydia pneumoniae, uso de uma proteìna, e, uso de um fragmento de ácido nucleico. |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US7264941B1 (pt) |
| EP (1) | EP1007685B1 (pt) |
| JP (1) | JP4160640B2 (pt) |
| CN (1) | CN1249233C (pt) |
| AT (1) | ATE323164T1 (pt) |
| AU (1) | AU749382B2 (pt) |
| BR (1) | BR9810288A (pt) |
| CA (1) | CA2294651A1 (pt) |
| DE (1) | DE69834194T2 (pt) |
| DK (1) | DK1007685T3 (pt) |
| ES (1) | ES2264810T3 (pt) |
| PT (1) | PT1007685E (pt) |
| WO (1) | WO1998058953A2 (pt) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6710033B1 (en) | 1996-08-14 | 2004-03-23 | Vanderbilt University | Methods and treatment of multiple sclerosis |
| US6890526B2 (en) | 1997-05-06 | 2005-05-10 | Vanderbilt University | Methods and reagents for the treatment of multiple sclerosis |
| US6649370B1 (en) * | 1998-10-28 | 2003-11-18 | Aventis Pasteur Limited | Chlamydia antigens and corresponding DNA fragments and uses thereof |
| WO2000024765A2 (en) * | 1998-10-28 | 2000-05-04 | Aventis Pasteur Limited | Chlamydia antigens and corresponding dna fragments and uses thereof |
| US6872814B2 (en) * | 1998-10-29 | 2005-03-29 | Aventis Pasteur Limited | Chlamydia antigens and corresponding DNA fragments and uses thereof |
| WO2000032784A1 (en) * | 1998-12-01 | 2000-06-08 | Aventis Pasteur Limited | Chlamydia antigens and corresponding dna fragments and uses thereof |
| WO2000032794A2 (en) * | 1998-12-01 | 2000-06-08 | Aventis Pasteur Limited | Chlamydia antigens and corresponding dna fragments and uses thereof |
| EP1163342B1 (en) * | 1999-03-12 | 2008-12-10 | Aventis Pasteur Limited | Chlamydia antigens and corresponding dna fragments and uses thereof |
| DE60036698T2 (de) | 1999-05-03 | 2008-07-24 | Sanofi Pasteur Ltd., Toronto | Chlamydia-antigene und entsprechende dna-fragmente und deren verwendungen |
| EP1220925B8 (en) | 1999-09-20 | 2008-04-23 | Sanofi Pasteur Limited | Chlamydia antigens and corresponding dna fragments and uses thereof |
| US20010048927A1 (en) | 2000-02-01 | 2001-12-06 | Richard Stephens | Porin B (PorB) as a therapeutic target for prevention and treatment of infection by chlamydia |
| ATE440861T1 (de) * | 2000-07-03 | 2009-09-15 | Novartis Vaccines & Diagnostic | Immunisierung gegen chlamydia pneumoniae |
| US7105171B2 (en) | 2002-03-07 | 2006-09-12 | The Regents Of The University Of California | Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia |
| WO2017192902A1 (en) | 2016-05-04 | 2017-11-09 | Children's Hospital & Research Center At Oakland | Rapid extraction of nucleic acids from clinical samples for downstream applications |
| EP3966568B1 (en) * | 2019-05-06 | 2024-07-03 | Arocell AB | Respiratory infection detection and classification |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU692889B2 (en) * | 1994-08-03 | 1998-06-18 | Hitachi Chemical Company, Ltd. | Monoclonal antibodies having a reactivity specific to Chlamydia pneumoniae, method for production of the monoclonal antibodies, such antibody producing cells, method for production of the cells, method for detection and/or measurement of Chlamydia pneumoniae, reagents for the method, method and agents for diagnosis of chlamydia pneumoniae infection |
| EP2045261A1 (en) | 1994-09-20 | 2009-04-08 | Hitachi Chemical Co., Ltd. | Chlamydia pneumoniae antigenic polypeptides |
| US6248329B1 (en) * | 1998-06-01 | 2001-06-19 | Ramaswamy Chandrashekar | Parasitic helminth cuticlin nucleic acid molecules and uses thereof |
-
1998
- 1998-06-19 CN CNB988064286A patent/CN1249233C/zh not_active Expired - Fee Related
- 1998-06-19 AU AU80119/98A patent/AU749382B2/en not_active Ceased
- 1998-06-19 CA CA002294651A patent/CA2294651A1/en not_active Abandoned
- 1998-06-19 JP JP50361399A patent/JP4160640B2/ja not_active Expired - Fee Related
- 1998-06-19 BR BR9810288-5A patent/BR9810288A/pt not_active Application Discontinuation
- 1998-06-19 WO PCT/DK1998/000266 patent/WO1998058953A2/en not_active Ceased
- 1998-06-19 AT AT98928179T patent/ATE323164T1/de not_active IP Right Cessation
- 1998-06-19 DE DE69834194T patent/DE69834194T2/de not_active Expired - Lifetime
- 1998-06-19 US US09/446,677 patent/US7264941B1/en not_active Expired - Fee Related
- 1998-06-19 DK DK98928179T patent/DK1007685T3/da active
- 1998-06-19 PT PT98928179T patent/PT1007685E/pt unknown
- 1998-06-19 ES ES98928179T patent/ES2264810T3/es not_active Expired - Lifetime
- 1998-06-19 EP EP98928179A patent/EP1007685B1/en not_active Expired - Lifetime
-
2007
- 2007-07-12 US US11/826,125 patent/US20080226679A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| DK1007685T3 (da) | 2006-08-14 |
| US7264941B1 (en) | 2007-09-04 |
| AU8011998A (en) | 1999-01-04 |
| JP4160640B2 (ja) | 2008-10-01 |
| EP1007685B1 (en) | 2006-04-12 |
| JP2002510970A (ja) | 2002-04-09 |
| CN1249233C (zh) | 2006-04-05 |
| US20080226679A1 (en) | 2008-09-18 |
| WO1998058953A2 (en) | 1998-12-30 |
| ES2264810T3 (es) | 2007-01-16 |
| CA2294651A1 (en) | 1998-12-30 |
| CN1261403A (zh) | 2000-07-26 |
| DE69834194D1 (de) | 2006-05-24 |
| WO1998058953A3 (en) | 1999-03-18 |
| DE69834194T2 (de) | 2007-03-29 |
| ATE323164T1 (de) | 2006-04-15 |
| PT1007685E (pt) | 2006-08-31 |
| EP1007685A2 (en) | 2000-06-14 |
| AU749382B2 (en) | 2002-06-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9810288A (pt) | Teste diagnóstico especìfico para espécie para identificar infecção de um mamìfero, como um humano, com chlamydia pneumoniae, fragmento de ácido nucleico derivado de chlamydia pneumoniae, proteìna derivada de chlamydia pneumoniae, anticorpo monoespecìfico policlonal, kit diagnóstico para o diagnóstico de infecção de um mamìfero, como um humano, com chlamydia pneumoniae, composição para imunizar um mamìfero comoum humano, contra chlamydia pneumoniae, uso de uma proteìna, e, uso de um fragmento de ácido nucleico. | |
| RU2339646C2 (ru) | Гибридная и тандемная экспрессия белков нейссерий | |
| AR003124A1 (es) | Proteinas estreptococicas de shock termico miembros de la familia de hsp7270,secuencia de adn que codifica para dichos polipeptidos, vector deexpresion, molecula de adn recombinante, metodo para producir un polipeptido o fragmento del mismo, anticuerpo o fragmento del mismo y anticuerpo monoclonal, | |
| BR0112602A (pt) | Compostos e métodos para tratamento e diagnóstico de infecção clamidial | |
| EA200000860A1 (ru) | Выделенный полинуклеотид (варианты), полинуклеотид (варианты), вектор (варианты), клетка-хозяин (варианты), выделенный полипептид (варианты), способ его получения (варианты), вакцинная композиция (варианты), способ терапевтического или профилактического лечения стрептококковой бактериальной инфекции у животного (варианты), применение (варианты) | |
| CN1322127C (zh) | 来自脑膜炎奈瑟氏球菌的basb029多核苷酸和多肽 | |
| BRPI0114510B8 (pt) | multímero de polipeptídeo monomérico purificado, composição de vacina para profilaxia ou tratamento da infecção por vírus da hepatite e em mamíferos, kit de diagnóstico para infecção por vírus da hepatite e em amostras biológicas, método de diagnóstico in vitro da infecção por vírus da hepatite e em mamíferos, método para detecção in vitro de anticorpos totais contra o vírus da hepatite e em amostras biológicas, método para detecção in vitro do anticorpo igg contra o vírus da hepatite e em amostras biológicas e método para detectar in vitro o anticorpo igm contra o vírus da hepatite e em amostras biológicas | |
| RU2006134631A (ru) | Иммуногенные композиции против chlamidia pneumoniae | |
| Zuffi et al. | Identification of an immunodominant peptide in the parvovirus B19 VP1 unique region able to elicit a long-lasting immune response in humans | |
| US12239696B2 (en) | Chimeric vaccine antigens for anaplasmosis | |
| JP2007526318A5 (pt) | ||
| KR930702942A (ko) | 재조합 고양이 코로나바이러스 에스 단백질 | |
| Centurion-Lara et al. | Conservation of the 15-kilodalton lipoprotein among Treponema pallidum subspecies and strains and other pathogenic treponemes: genetic and antigenic analyses | |
| Guarino et al. | Indirect ELISA for the diagnosis of brucellosis in water buffaloes (Bubalus bubalis) in Italy | |
| CN100386430C (zh) | 用于犬和人埃利希病的免疫诊断的p153和p156抗原及其用途 | |
| JPH06508513A (ja) | マイコバクテリウムタンパク質およびその使用 | |
| KR100366482B1 (ko) | 백신으로서 정제된 분류가능하지 않은 헤모필루스 인프루엔자 p5단백질, 및 그의 정제방법 | |
| BRPI0413857A (pt) | seqüência de ácido nucleico, fragmento de dna, molécula de dna recombinante, veìculo recombinante vivo, célula hispedeira, proteìna de lawsonia intracellularis, uso de uma proteìna de lawsonia intracellularis, vacina para combater infecções por lawsonia intracellularis, método para a preparação de uma vacina, e, teste diagnóstico | |
| US10022458B2 (en) | Animal model protocol, diagnostic, therapeutic and vaccine against digital dermatitis | |
| CN117603366B (zh) | 一种布鲁氏菌特异性融合抗原及其应用 | |
| EP3762725B1 (en) | Species specific antigen sequences for tick-borne relapsing fever (tbrf) and methods of use | |
| EP1054895B1 (en) | Novel peptide diagnostic reagent and kit for detection of rickettsiosis | |
| DE60025522T2 (de) | Mycoplasma mycoides subsp. mycoides sc antigenisches lppq protein, seine herstellung und verwendung | |
| RU2000131225A (ru) | Белки moraxella catarrhalis | |
| MX2010009516A (es) | Secuencias novedosas de brachyspira, composiciones inmunogenicas, metodos para la preparacion y usos de las mismas. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 10 (VIII E IX), 18 (III), 24 E 25 DA LPI. |
|
| B15K | Others concerning applications: alteration of classification |
Free format text: ALTERADA A CLASSIFICACAO DE INT. CL. 6A.: C07K 14/00 PARA INT. CL 2009.01: C12N 15/31, G01N 33/68,C07K 14/295, A61K 39/118, G01N 33/569, C12Q 1/68 E C07K 16/12. Ipc: C12N 15/31 (2010.01), G01N 33/68 (2010.01), C07K 1 |
|
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |